Clinical Trials Search Results

  • Resize font
  • Print
  • Email
  • Facebook
  • Twitter
  • Google+
  • Pinterest

Initial search results include only NCI-sponsored clinical trials. To search all trials, click the "REFINE SEARCH" button, scroll down to the Trial ID/Sponsor section and select the "All" check box in the Sponsor of Trial section.

View Content for:
Display:
?
Drug:  tanomastat
Find trials that include:  Any drugs shown
Trial Status:  Closed
Results 1-5 of 5 for your search:
Start Over
Phase III Randomized Study of BAY 12-9566 Versus Gemcitabine in Patients With Advanced or Metastatic Adenocarcinoma of the Pancreas
Phase: Phase III
Type: Treatment
Status: Closed
Age: 18 and over
Sponsor: Pharmaceutical / Industry
Protocol IDs: CAN-NCIC-PA1, BAYER-STR-CO2, PA1
Phase III Randomized Study of BAY 12-9566 Versus Placebo in Patients with Small Cell Lung Cancer in Complete or Partial Remission (Summary Last Modified 11/1999)
Phase: Phase III
Type: Treatment
Status: Closed
Age: 18 and over
Sponsor: Pharmaceutical / Industry
Protocol IDs: BAYER-12-9566/D97-027, CWRU-BAYR-1597, IMPACT-100009, NCI-V98-1411
Phase III Randomized Study of BAY 12-9566 versus Placebo in Patients With Stage IIIA or IIIB Non-Small Cell Lung Cancer (Summary Last Modified 11/1999)
Phase: Phase III
Type: Treatment
Status: Closed
Age: 18 and over
Sponsor: Pharmaceutical / Industry
Protocol IDs: BAYER-12-9566/D97-028, BAYER-12-9566, RPCI-DS-9803
Phase I Study of BAY-12-9566 in Patients With Advanced Cancer (Summary Last Modified 03/98)
Phase: Phase I
Type: Treatment
Status: Closed
Age: 18 and over
Sponsor: Pharmaceutical / Industry
Protocol IDs: CAN-NCIC-IND107, BAYER-12-9566/STRCPI, IND107
Phase I Study of BAY 12-9566 and Fluorouracil or Doxorubicin in Patients with Cancer
Phase: Phase I
Type: Treatment
Status: Closed
Age: 18 and over
Sponsor:
Protocol IDs: CAN-NCIC-IND113, BAYER-STR-C01, IND113
Start Over